Log In
Print this Print this

GS 6620

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionNucleotide polymerase inhibitor
Molecular Target Viral DNA polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat hepatitis C virus (HCV) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today